3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Solid Tumor
1
Breast Neoplasms
1
Interventions
Everolimus
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thymus Neoplasms
×
Histocompatibility Testing
×
30 days
×
Clear all
No trials found.